By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Theravance, Inc. 

901 Gateway Boulevard

South San Francisco  California  94080  U.S.A.
Phone: 650-808-6000 Fax: 650-827-8690



Company News
Theravance, Inc. (THRX) Announces Positive Top-Line Results From Phase 2b Dose-Ranging Study Of Its Investigational LAMA, TD-4208, For The Treatment Of COPD 9/9/2014 11:16:24 AM
Theravance, Inc. (THRX) Provides VIBATIV® (telavancin) Product Update 9/9/2014 11:13:59 AM
Theravance, Inc. (THRX) To Present At The Baird 2014 Health Care Conference 8/22/2014 11:01:44 AM
Theravance, Inc. (THRX) Reports Second Quarter 2014 Financial Results 8/7/2014 10:57:59 AM
South San Francisco's Theravance, Inc. (THRX) Brings In A New CEO 8/6/2014 3:50:47 PM
Theravance, Inc. (THRX) To Report Second Quarter 2014 Financial Results On August 6, 2014 7/31/2014 12:45:46 PM
GlaxoSmithKline (GSK), Theravance, Inc. (THRX) Begin Pivotal Phase 3 Trial For Triple Combination Treatment 7/16/2014 7:42:21 AM
Theravance, Inc. (THRX) Release: Anoro® Ellipta® (Umeclidinium/Vilanterol) Gains Approval In Japan For The Treatment Of COPD 7/7/2014 12:28:54 PM
Theravance, Inc. (THRX) Appoints Theodore J. Witek, Jr. As Senior Vice President, Corporate Partnerships, Clinical And Medical Affairs 7/3/2014 9:21:35 AM
GlaxoSmithKline (GSK) And Theravance, Inc. (THRX) Announce Submission To US Regulatory Authorities For Fluticasone Furoate/Vilanterol In Asthma 6/30/2014 11:10:57 AM